We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Colin and his team killed all sentiments no trust share holders needs assurance not lies and radio silents
I agree that the shareholders beleive "that ODX now have a capacity to produce 100 million tests per annum".
The real problem is whether the shareholders have faith that the company in its current form are capable of selling them.
That is unusual to public RNS and clean all Covid off as shareholder don't care about other than Covid test kit. How this company make it again when all they public and their website tell about contact value at 347 million. In case long stop expiry they must noice to market by RNS about that if they cant fillfull contact and that is big impact and vary have financial to company . they didnot do that and not sure at the moments what is state of contact .Why company said no manufacture test kit for GOV ?
Why so many investors get attached too company's move on,
Drlong, I agree. In our contempt for the CEO, the ODX Board of Directors and the comm’s, we have lost the point. The stock market works by attempting to value the future potential of a company, what opportunity it represents. I will not bother to list the many ongoing approvals we have in progress and I don’t think any of us, whatever our disappointment at this stage, disbelieve that ODX now have a capacity to produce 100 million tests per annum and few of us doubt that Covid will be around for a while yet and LFT will be required at home and across the world. I still hold to a market price for LFT’s to be around £3.75 and I remain comfortable that our costs to manufacture are no more than £2. Others have suggested that OG sell tests for £2.75 (from memory), quite possibly, it is amazing how paying your employees a few $ a day can help with your overheads. I could argue that HMG would be better paying £3.75 for a UK produced product than importing from China at £2.75 but even if the harsh reality is that ODX had to match this price in the market that would still present a major opportunity. OK my aspirations of £2.50 a share seem long dead, at least whilst I type but 25p really? At £2.75 and producing at full capacity and a p/e of only 3 would comfortably give us £1.24. We are all dissatisfied with the way this company has been managed, this is a separate thing to the company having the opportunity to manufacture 100 million LFT per annum.
I am as financially hurt, angry and contemptuous for the way we appear to have been misled, as anyone. What were they possibly thinking? How could they have acted so badly? Why would they issue so many tweets to confirm our bias that they were busy, negotiating hard on a government contract that would surely slot into place imminently and of course that commercial opportunities in the USA would play a large part in our future? All shocking and we certainly have a right to question their credibility, seek to have them removed and possibly sanctioned but we must not let our justifiable pain blind us to any positives that have managed to hang in there despite everything else.
I do not believe a take over at this stage would be to our advantage we need approvals and orders first to have any chance at receiving fair value. We have cash in the bank to certainly see us through 12 months, probably longer but certainly until we can actually start producing. Investors are hurting but let’s not let our own disappointment and anger blind us to the reality of producing 100m tests per annum - with this board or a new one.
Can change on a dime .look at gdr and they havent sold a single thing.
Db for gdr has been hammered endlessly for a while now.but sentiment changed very quickly